Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial

This study outlines the safety of the autologous SVF cells injection in the hands of patients with SSc. Preliminary assessments at 6 months suggest potential efficacy needing confirmation in a randomised placebo-controlled trial on a larger population. Funding GFRS (Groupe Francophone de Recherche sur la Sclérodermie). Clinical Trials number NCT01813279.

http://ard.bmj.com/cgi/content/short/74/12/2175?rss=1

Source: Annals of the Rheumatic Diseases - November 10, 2015 Category: Rheumatology Authors: Granel, B., Daumas, A., Jouve, E., Harle, J.-R., Nguyen, P.-S., Chabannon, C., Colavolpe, N., Reynier, J.-C., Truillet, R., Mallet, S., Baiada, A., Casanova, D., Giraudo, L., Arnaud, L., Veran, J., Sabatier, F., Magalon, G. Tags: Open access, Immunology (including allergy), Pain (neurology), Connective tissue disease, Epidemiology Clinical and epidemiological research Source Type: research